• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微菌素25,一种由大肠杆菌产生的新型抗菌肽。

Microcin 25, a novel antimicrobial peptide produced by Escherichia coli.

作者信息

Salomón R A, Farías R N

机构信息

Departamento de Bioquímica de la Nutrición, Instituto Superior de Investigaciones Biológicas (Consejo Nacional de Investigaciones Científicas y Técnicas-UNT), Tucumán, Argentina.

出版信息

J Bacteriol. 1992 Nov;174(22):7428-35. doi: 10.1128/jb.174.22.7428-7435.1992.

DOI:10.1128/jb.174.22.7428-7435.1992
PMID:1429464
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC207439/
Abstract

Microcin 25, a peptide antibiotic excreted by an Escherichia coli strain isolated from human feces, was purified to homogeneity and characterized. Composition analysis and data from gel filtration indicated that microcin 25 may contain 20 amino acid residues. It has a blocked amino-terminal end. Microcin synthesis and immunity are plasmid determined, and the antibiotic was produced in minimal medium when the cultures entered the stationary phase of growth. The peptide appears to interfere with cell division, since susceptible cells filamented when exposed to it. This response does not seem to be mediated by the SOS system.

摘要

微菌素25是一种从人类粪便中分离出的大肠杆菌菌株分泌的肽抗生素,已被纯化至同质并进行了特性鉴定。组成分析和凝胶过滤数据表明,微菌素25可能含有20个氨基酸残基。它的氨基末端是封闭的。微菌素的合成和免疫由质粒决定,当培养物进入生长稳定期时,该抗生素在基本培养基中产生。该肽似乎会干扰细胞分裂,因为敏感细胞在接触它时会形成丝状体。这种反应似乎不是由SOS系统介导的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e18/207439/fb87f752932c/jbacter00088-0373-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e18/207439/fb87f752932c/jbacter00088-0373-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0e18/207439/fb87f752932c/jbacter00088-0373-a.jpg

相似文献

1
Microcin 25, a novel antimicrobial peptide produced by Escherichia coli.微菌素25,一种由大肠杆菌产生的新型抗菌肽。
J Bacteriol. 1992 Nov;174(22):7428-35. doi: 10.1128/jb.174.22.7428-7435.1992.
2
[Microcin R51 and a plasmid determining its synthesis].[微菌素R51及其合成决定质粒]
Mol Gen Mikrobiol Virusol. 1990 May(5):12-7.
3
Microcin 7: purification and properties.微菌素7:纯化与特性
Biochem Biophys Res Commun. 1984 Mar 15;119(2):779-85. doi: 10.1016/s0006-291x(84)80318-6.
4
Detection of microcin production by pathogenic Escherichia coli isolates from children with acute diarrhoea.检测急性腹泻儿童致病性大肠杆菌分离株的微菌素产生情况。
Acta Cient Venez. 1994;45(2):106-11.
5
Purification and characterization of the antimicrobial peptide microcin N.微菌素 N 的抗菌肽的纯化与特性分析。
FEMS Microbiol Lett. 2010 Nov;312(2):119-25. doi: 10.1111/j.1574-6968.2010.02106.x.
6
Characterization of a highly potent antimicrobial peptide microcin N from uropathogenic Escherichia coli.来自尿路致病性大肠杆菌的高效抗菌肽微菌素N的特性分析。
FEMS Microbiol Lett. 2016 Jun;363(11). doi: 10.1093/femsle/fnw095. Epub 2016 Apr 15.
7
Cloning of the determinants for microcin D93 production and analysis of three different D-type microcin plasmids.微小菌素D93产生决定因子的克隆及三种不同D型微小菌素质粒的分析
Plasmid. 1990 May;23(3):216-25. doi: 10.1016/0147-619x(90)90053-f.
8
Antibiotic resistance in Salmonella enterica serovar Typhimurium exposed to microcin-producing Escherichia coli.暴露于产微菌素大肠杆菌的肠炎沙门氏菌鼠伤寒血清型中的抗生素耐药性
Appl Environ Microbiol. 2001 Aug;67(8):3763-6. doi: 10.1128/AEM.67.8.3763-3766.2001.
9
Cloning and mapping of the genetic determinants for microcin C51 production and immunity.微菌素C51产生及免疫的遗传决定因素的克隆与定位
Mol Gen Genet. 1993 Dec;241(5-6):700-6. doi: 10.1007/BF00279914.
10
Isolation, purification and partial amino acid sequence of a highly hydrophobic new microcin named microcin L produced by Escherichia coli.由大肠杆菌产生的一种名为微菌素L的高度疏水新微菌素的分离、纯化及部分氨基酸序列
FEMS Microbiol Lett. 2000 Dec 1;193(1):95-8. doi: 10.1111/j.1574-6968.2000.tb09408.x.

引用本文的文献

1
LassoPred: a tool to predict the 3D structure of lasso peptides.套索肽预测工具:一种预测套索肽三维结构的工具。
Nat Commun. 2025 Jul 1;16(1):5497. doi: 10.1038/s41467-025-60544-4.
2
Being a better version of yourself: genetically engineered probiotic bacteria as host defense enhancers in the control of intestinal pathogens.成为更好的自己:基因工程益生菌作为宿主防御增强剂用于控制肠道病原体
Gut Microbes. 2025 Dec;17(1):2519696. doi: 10.1080/19490976.2025.2519696. Epub 2025 Jun 18.
3
Exploring the bioactive landscape: peptides and non-peptides from the human microbiota.

本文引用的文献

1
Chromatographic determination of cystine as cysteic acid.以半胱磺酸形式进行色谱法测定胱氨酸。
Biochem J. 1954 May;57(1):33-7. doi: 10.1042/bj0570033.
2
Synthesis of penicillin-binding protein 6 by stationary-phase Escherichia coli.稳定期大肠杆菌青霉素结合蛋白6的合成
J Bacteriol. 1982 Jul;151(1):491-4. doi: 10.1128/jb.151.1.491-494.1982.
3
Control of antibiotic biosynthesis.抗生素生物合成的控制
探索生物活性全景:来自人类微生物群的肽类和非肽类物质
NPJ Biofilms Microbiomes. 2025 May 8;11(1):76. doi: 10.1038/s41522-025-00713-x.
4
Lasso peptides: A focus on therapeutic index.套索肽:关注治疗指数。
World J Microbiol Biotechnol. 2025 Apr 28;41(5):151. doi: 10.1007/s11274-025-04374-y.
5
Predicting 3D Structures of Lasso Peptides.预测套索肽的三维结构。
Res Sq. 2025 Apr 1:rs.3.rs-4579522. doi: 10.21203/rs.3.rs-4579522/v1.
6
Lasso peptides sviceucin and siamycin I exhibit anti-virulence activity and restore vancomycin effectiveness in vancomycin-resistant pathogens.套索肽sviceucin和西阿霉素I表现出抗毒力活性,并恢复了万古霉素对耐万古霉素病原体的有效性。
iScience. 2025 Jan 30;28(3):111922. doi: 10.1016/j.isci.2025.111922. eCollection 2025 Mar 21.
7
Evolution-Guided Discovery of Antimycobacterial Triculamin-Like Lasso Peptides.基于进化引导发现抗分枝杆菌的类三氯拉明套索肽
Angew Chem Int Ed Engl. 2025 May 12;64(20):e202425134. doi: 10.1002/anie.202425134. Epub 2025 Mar 5.
8
The lasso structure, biosynthesis, bioactivities and potential applications of Microcin J25: A novel antibacterial agent with unique mechanisms.微小菌素J25的套索结构、生物合成、生物活性及潜在应用:一种具有独特作用机制的新型抗菌剂
Eng Microbiol. 2023 May 16;3(3):100096. doi: 10.1016/j.engmic.2023.100096. eCollection 2023 Sep.
9
Advances in lasso peptide discovery, biosynthesis, and function.lasso 肽的发现、生物合成和功能的研究进展。
Trends Genet. 2024 Nov;40(11):950-968. doi: 10.1016/j.tig.2024.08.002. Epub 2024 Aug 31.
10
Structure Prediction and Protein Engineering Yield New Insights into Microcin J25 Precursor Recognition.结构预测和蛋白质工程为微菌素 J25 前体识别提供新的见解。
ACS Chem Biol. 2024 Sep 20;19(9):1982-1990. doi: 10.1021/acschembio.4c00251. Epub 2024 Aug 20.
Microbiol Rev. 1980 Jun;44(2):230-51. doi: 10.1128/mr.44.2.230-251.1980.
4
Excretion of a protease by Serratia marcescens.粘质沙雷氏菌蛋白酶的排泄
Arch Microbiol. 1980 Jan;124(1):55-61. doi: 10.1007/BF00407028.
5
Genetic and physiological characterization of Escherichia coli mutants deficient in phosphoenolpyruvate carboxykinase activity.缺乏磷酸烯醇丙酮酸羧激酶活性的大肠杆菌突变体的遗传和生理学特征
J Bacteriol. 1980 Mar;141(3):1115-21. doi: 10.1128/jb.141.3.1115-1121.1980.
6
Evidence for involvement of penicillin-binding protein 3 in murein synthesis during septation but not during cell elongation.有证据表明青霉素结合蛋白3参与隔膜形成过程中的胞壁质合成,但不参与细胞伸长过程中的胞壁质合成。
J Bacteriol. 1981 Jan;145(1):333-40. doi: 10.1128/jb.145.1.333-340.1981.
7
The ins and outs of colicins. Part I: Production, and translocation across membranes.大肠杆菌素的来龙去脉。第一部分:产生及跨膜转运。
Microbiol Sci. 1984 Oct;1(7):168-75.
8
Purification and characterization of pro-TraTp, the signal sequence-containing precursor of a secreted protein encoded by the F sex factor.F 性因子编码的一种分泌蛋白含信号序列前体 pro-TraTp 的纯化与特性分析
J Bacteriol. 1984 May;158(2):464-73. doi: 10.1128/jb.158.2.464-473.1984.
9
Microcin 7: purification and properties.微菌素7:纯化与特性
Biochem Biophys Res Commun. 1984 Mar 15;119(2):779-85. doi: 10.1016/s0006-291x(84)80318-6.
10
The acid phosphatase with optimum pH of 2.5 of Escherichia coli. Physiological and Biochemical study.大肠杆菌中最适pH为2.5的酸性磷酸酶。生理与生化研究。
J Biol Chem. 1982 Jun 25;257(12):6669-76.